Cargando…
Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
Autor principal: | Standing, Joseph F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704430/ https://www.ncbi.nlm.nih.gov/pubmed/36101504 http://dx.doi.org/10.1093/jac/dkac305 |
Ejemplares similares
-
Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
por: Zhao, Yang, et al.
Publicado: (2020) -
Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
por: Downs, J. T., et al.
Publicado: (1986) -
Population pharmacokinetics and dose optimization of vancomycin in neonates
por: Lee, Soon Min, et al.
Publicado: (2021) -
Development of a High Performance Liquid
Chromatographic Assay Measuring Mezlocillin in
Serum or Tissue
por: Mya, Sandra, et al.
Publicado: (1993) -
Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies
por: Germovsek, Eva, et al.
Publicado: (2018)